| Cholera toxin: a paradigm of a multifunctional protein K Bharati, NK Ganguly The Indian journal of medical research 133 (2), 179, 2011 | 100 | 2011 |
| Immunogenicity and protective efficacy of the E. coli-expressed domain III of Japanese encephalitis virus envelope protein in mice K Bharati, YPS Malik, S Vrati Medical microbiology and immunology 196 (4), 227-231, 2007 | 45 | 2007 |
| Japanese encephalitis: development of new candidate vaccines K Bharati, S Vrati Expert review of anti-infective therapy 4 (2), 313-324, 2006 | 40 | 2006 |
| Tackling the malaria problem in the South-East Asia Region: need for a change in policy? K Bharati, NK Ganguly The Indian journal of medical research 137 (1), 36, 2013 | 30 | 2013 |
| Novel sequences encoding venom C-type lectins are conserved in phylogenetically and geographically distinct Echis and Bitis viper species RA Harrison, J Oliver, SS Hasson, K Bharati, RDG Theakston Gene 315, 95-102, 2003 | 29 | 2003 |
| Molecular cloning of phospholipases A2 from venom glands of Echis carpet vipers K Bharati, SS Hasson, J Oliver, GD Laing, RDG Theakston, RA Harrison Toxicon 41 (8), 941-947, 2003 | 28 | 2003 |
| Effect of cytokine‐encoding plasmid delivery on immune response to Japanese encephalitis virus DNA vaccine in mice K Bharati, MB Appaiahgari, S Vrati Microbiology and immunology 49 (4), 349-353, 2005 | 22 | 2005 |
| Evaluation of Japanese encephalitis virus DNA vaccine candidates in rhesus monkeys [Macaca mulatta] K Bharati, R Rani, S Vrati Vaccine 27 (1), 10-16, 2009 | 18 | 2009 |
| Why is the oral cholera vaccine not considered an option for prevention of cholera in India? Analysis of possible reasons SS Gupta, K Bharati, D Sur, A Khera, NK Ganguly, GB Nair The Indian journal of medical research 143 (5), 545, 2016 | 15 | 2016 |
| Cholera outbreaks in South-East Asia K Bharati, SK Bhattacharya Cholera Outbreaks, 87-116, 2014 | 12 | 2014 |
| Japanese encephalitis S Vrati, K Bharati | 9* | 2000 |
| Does India need an indigenous HPV vaccine and why? K Bharati, NK Ganguly Journal of public health policy 34 (2), 272-287, 2013 | 7 | 2013 |
| Molecular cloning and characterization of chikungunya virus genes from Indian isolate of 2006 outbreak S Gupta, S Vrati J Pharm Res 55, 3860-3863, 2012 | 7 | 2012 |
| Snakebite management in the tropics K Bharati, AK Hati SCIENCE AND CULTURE 66 (9/10), 302-304, 2000 | 3 | 2000 |
| Viral vaccines in India: an overview K Bharati, S Vrati Proceedings of the National Academy of Sciences, India Section B: Biological …, 2012 | 2 | 2012 |
| DNA vaccines: Getting closer to becoming a reality K Bharati, S Vrati The Indian journal of medical research 137 (6), 1027, 2013 | 1 | 2013 |
| NEUTRALIZATION POTENCY OF GAMMA IRRADIATED RUSSELL'S VIPER VENOM TOXOID ANTISERUM RAISED IN RHESUS MONKEYS, AS AGAINST COMMERCIAL ANTISERUM K Bharati, AK Hati Indian Journal of Physiology and Allied Sciences 54 (3), 159-164, 2000 | 1 | 2000 |
| Focussing on ‘mental hygiene’along with ‘hand hygiene’in the times of COVID-19 MS Sen, N Chawla, R Sagar Indian Journal of Medical Research 153 (1), 238, 2021 | | 2021 |
| Challenges in Delivering Optimal Healthcare to COVID-19 Patients: Focus on Delhi, India K Bharati, A Garg, S Das | | 2020 |
| Why did Chikungunya Return with a Vengeance? H Jain, K Bharati International Journal of Medical Reviews and Case Reports 3 (9), 609-612, 2019 | | 2019 |
Sudhanshu VratiExecutive Director, Regional Centre for BiotechnologyVerified email at rcb.res.in
